About Invokana
Invokana is a Healthcare company. It offers pharmaceutical solutions for managing type 2 diabetes and related health risks. It operates on a B2C model. Invokana offers products and services including INVOKANA and INVOKAMET. Its focus areas include Pharmaceuticals, Diabetes Treatment, SGLT2 Inhibitors and Kidney Disease Management.
Company details
Johnson Johnson markets INVOKANA, a drug that lowers blood sugar levels and reduces risks of kidney disease and cardiovascular events in adults with type 2 diabetes. It works alongside diet and exercise, targeting specific proteins in the body. The company provides consumer support through educational resources and cost options on their website, focusing on diabetes management without early symptoms awareness.
- SectorsHealthcare
- Website invokana.com
Products & Services of Invokana
Invokana offers a comprehensive portfolio of products and services, including INVOKANA and INVOKAMET.
Drug that lowers blood sugar and reduces kidney disease risk for type 2 diabetes patients.
Combined treatment for type 2 diabetes to manage blood sugar levels effectively.
Web traffic of Invokana
Websites that share an audience with Invokana (invokana.com).
Websites whose visitors overlap most with Invokana. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| januvia.com | 100% | 15.4K | #1,731,010 | View details | |
| tradjenta.com | 46% | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Invokana
Complete news archive for Invokana
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invokana
Johnson Johnson markets INVOKANA, a drug that lowers blood sugar levels and reduces risks of kidney disease and cardiovascular events in adults with type 2 diabetes. It works alongside diet and exercise, targeting specific proteins in the body. The company provides consumer support through educational resources and cost options on their website, focusing on diabetes management without early symptoms awareness.
Invokana offers INVOKANA and INVOKAMET.